Rare diseases
Investigational molecules
Locations
1 Rue Cabanis, 75014 Paris, France
Clinical research in Alzheimer disease focuses on disease progression, cognitive decline, and the relationship between microglial activation, tau pathology, and synaptic density using positron emission tomography imaging.
Research activity also includes biomarker-oriented work in early Alzheimer disease and longitudinal assessment of neurological deterioration.
Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience runs clinical trials in conditions such as Dementia Alzheimer's type, Depression, Subarachnoid haemorrhage, Anorexia nervosa, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceStudy on Psilocybin and Trazodone for Adults with Treatment-Resistant Depression
FranceStudy of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage
FranceStudy on the Effects of Donepezil in Patients with Anorexia Nervosa
FranceRituximab versus azathioprine for remission maintenance in patients with primary angiitis of the central nervous system – randomized controlled trial
FranceStudy on the Effectiveness of Calcium Folinate, Omega-3-Acid Ethyl Esters, and Cyanocobalamin for Patients at High Risk of Psychosis or Experiencing First Episode Psychosis
FranceStudy of microglial activation and synaptic density using [18F]-DPA-714, [18F]-Ro948, [11C]-UCB-J, and [11C]PiB PET imaging in patients with Alzheimer's disease
FranceA study of low-dose interleukin-2 (aldesleukin) treatment in patients with early Alzheimer's Disease
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
